NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells

Oct 29, 2022Journal of neuro-oncology

NMDA receptor activity may increase temozolomide resistance by raising MGMT levels in glioblastoma cells

AI simplified

Abstract

Activation of N-methyl-D-aspartate receptors (NMDAR) elevated MGMT expression and suppressed the effect of temozolomide (TMZ) in glioblastoma cells.

  • NMDAR signaling is associated with increased expression of MGMT, a DNA repair enzyme linked to TMZ resistance.
  • Knockdown of NMDAR decreased MGMT expression, enhancing the effectiveness of TMZ in T98G cells.
  • The combination of TMZ with memantine (MEM), an NMDAR antagonist, increased the cytotoxicity of TMZ.
  • Inhibition of NMDAR by MEM resulted in reduced MGMT expression and increased DNA alkylation by TMZ.
  • NMDAR signaling may play a crucial role in the chemoresistance of glioblastoma to TMZ.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free